VIM and carcinoma: The injected exp‐CAF2 cells (human vimentin‐positive) were detected in considerable numbers in 30‐day‐old primary tumors (Fig. 4G), demonstrating that exp‐CAF2 cells present in advanced tumors could continuously produce TGF‐β1 to influence nearby carcinoma cells.